Abstract:Introduction: Dendritic cells (DCs) have long been thought to function as passenger leukocytes that instigate the host anti-allograft response. However, there is cumulative evidence that DCs are not only stimulators of T cells but also play crucial roles in central and peripheral tolerance. Recently, the processing and presentation of antigens by different types of DCs have been appreciated as the initial events involved in determining immune responses. When exposed to inflammatory conditions, tolerogenic DCs, which have an immature phenotype, inhibit T cell responses and favor regulatory T cell induction/expansion. Methods: Human immune systerm has been reconstructed in NOD/SCID mouse by transplanting fetal human thymus, liver tissue and CD34+ cells. Before allo skin transplantation in humanized NOD/SCID mouse, the ILT3high DCs had been injected. After the skin transplantation from the 5th day, the survival time and morphological changes of the trasplanted grafts were observed. On the 7th day, the rejection degrees of skin grafts observed with HE staining were classified. In vivo, the change of T cell-subsets in peripheral blood was detected by flow cytometry, and ELISA was used to determine the dynamic changes of serum cytokines IL-2 and IL-10 of the recipients after transplantation. Results: After reconstruction of human immune systerm in NOD/SCID mouse, human CD4+ and CD8+ T cells were detected in peripheral blood, and the level increased until 16w˜20w. Allogeneic skin grafts could survive only 9-14d, because of rejectation. In the skin transplantation model, the ILT3high DCs group could better suppress rejction and prolong allogeneic skin graft survival time, reduce graft pathological damage. 7 days after skin transplantation, one-way MLR was used to detect donors and recipients in each group and found that the reactivity of the re-stimulation of ILT3high DCs group was significantly lower than that in other groups (P < 0.05). In vivo, ILT3high DCs could inhibit the secretion of IL-2, and promoted the the secretion of IL-10. And the Tregs level of ILT3high DCs group was significantly higher (p< 0.05vs control group) in peripheral blood, which was consistent with the results of quantitative analysis of Foxp3 mRNA with RT-PCR. Conclusions: This Atifical ILT3high DCs could significantly inhibited the lymphocyte proliferation, activation, and lymphocyte reactivity of the recipient in vivo, and significantly prolong the survival time of skin graft, and reduce the pathological of rejectional damage.

Evaluation of immunosuppression protocols for MHC-matched allogeneic iPS cell-based transplantation using a mouse skin transplantation model

An Efficient Combination Immunotherapy for Antitumor Immunity Without Accelerating Cardiac Allograft Rejection.

Short-term Pharmacological Inhibition of MyD88 Homodimerization by a Novel Inhibitor Promotes Robust Allograft Tolerance in Mouse Cardiac and Skin Transplantation.

Fit-For-All iPSC-Derived Cell Therapies and Their Evaluation in Humanized Mice With NK Cell Immunity

Establishment of an Allogenetic Skin Transplant Model in Mice for Evaluating Immunosuppressive Drugs

CD8+ T cell-mediated rejection of allogenic human-induced pluripotent stem cell-derived cardiomyocyte sheets in human PBMC-transferred NOG MHC double knockout mice

Regulatory T Cell Therapy for the Induction of Clinical Organ Transplantation Tolerance

Humanized Mouse Model as a Novel Approach in the Assessment of Human Allogeneic Responses in Organ Transplantation

Enhanced allogeneic skin-graft survival using sCD95L, sCD152, interleukin-10 and transforming growth factor-β in combination, and comparison with ciclosporin

Evaluation of the immunogenicity of human iPS cell-derived neural stem/progenitor cells in vitro

Ipsc-Derived Regulatory Dendritic Cells Inhibit Allograft Rejection by Generating Alloantigen-Specific Regulatory T Cells.

Donor Specific Tolerance for MHC Mis-Matched Murine Skin Allograft Induced by Donor Bone Marrow Transplantation with Precondition of High Dose Immunosuppressants

Immunogenicity and Functional Evaluation of Ipsc-Derived Organs for Transplantation

An Immunotherapeutic Strategy for Prolonging Graft Survival in Mice.

Prolonged Survival of Skin Graft by Dendritic Cells Derived Donor-Specific Ilt3 Lentivirus-Transduced Human Cd34(+) Cells in Hu-Nod/Scid Mice

Control of allograft rejection in mice by applying a novel neuropeptide, cortistatin

Cell Communication‐Mediated Selective Drug Delivery for Epitope‐Specific Deletion of Alloreactive T Cells in Organ Transplant

Induction of Immunotolerance in Mice after Skin Allotransplantation by Subcutaneous Injection of Bone Marrow

CTLA4-Ig alleviates the allogeneic immune responses against insulin-producing cells in a murine model of cell transplantation

MHC matching improves engraftment of iPSC-derived neurons in non-human primates

Guiding Postablative Lymphocyte Reconstitution as a Route Toward Transplantation Tolerance